Responsive and scheduled neurostimulation for epilepsy

Domain IX · Biomedical, neuro & digital · 2013 · USA

What it is

Responsive and scheduled neurostimulation for epilepsy is not a psychotherapy. It is a group of implanted medical devices that epilepsy neurology, neurophysiology and neurosurgery teams select, implant and programme as an add-on (adjunctive) treatment for drug-resistant epilepsy. Three device…

Format

• The device pathway is run by the epilepsy team; the phases below map the psychotherapist's work onto it. Session counts are not specified in any device source; the numbers given are. The ILAE supports individual, group, home-based and telehealth formats (STRONG).
• Typical: 2–4 sessions, or folded into ongoing therapy.

Who practises it, and how they are trained or regulated

• Therapist goals: baseline assessment of depression, anxiety, suicidality, psychosis history, cognition complaints, substance use and social supports; psychoeducation; begin or continue treatment of any comorbid disorder. The DBS labelling asks clinicians to assess depression before surgery and weigh it against expected benefit. The RNS pivotal trial excluded people with active psychosis, severe depression or…
• Version followed: US device labelling as the manufacturers and FDA publish it (NeuroPace RNS System brief statement DN 1014760 Rev 4 and FDA PMA P100026 summary; Medtronic DBS epilepsy indication and safety text; LivaNova VNS Therapy US safety information), NICE HealthTech guidance HTG550 (formerly IPG678) for the UK, and for the psychological role the ILAE Psychology Task Force recommendations (Michaelis et al.,…
• Regulatory status (as of October 2026, per the sources named).

Questions to explore with your client

• What drew you to it, and what are you hoping it will change?
• Is there physical contact? Was it explained beforehand, and do you feel free to say no or stop at any point?
• Does it involve any substance, plant preparation, remedy or supplement? Has your doctor or prescriber been told, especially about any medication you take?
• Does it involve intense or unusual breathing? Have you been told about the medical conditions for which that is not advised?
• Does it involve fasting, a special diet or 'detox'? Have you discussed this with your doctor?
• Who runs it, and what training or registration do they hold?
• What actually happens in a session or meeting, and how often?
• What does it cost, and is there pressure to commit to more?
• How do you feel afterwards, in the hours and days that follow?
• Does it fit with, or clash with, the work we do here?

What practitioners of it watch for

• fragmented care across services.
• sudden change or confusion (report promptly).
• abrupt loss of contact after a device decision.
• all-or-nothing appraisal of the device; withdrawal; overprotection by family.
• consent driven by hopelessness; inability to recall key risks; avoidance of the topic.

When to involve someone else

• New or worsening physical symptoms, or advice to stop or change prescribed medication: involve the client's doctor or prescriber.
• Signs of coercion, isolation from family and friends, escalating costs or secrecy: discuss openly and consider safeguarding.
• A crisis or thoughts of suicide: follow your crisis protocol. In the US, call or text 988; in the UK and Ireland, Samaritans on 116 123.

Drawn automatically from the guide's own sections. Stay curious: neither endorse nor dismiss what the client values, and check anything that matters against the full guide and its sources. Not medical advice.